Bayer Cropscience India Limited
3,386.40
INR
-63.20
(-1.83%)
ISIN
INE462A01022
Return %
Stock
S&P 500
1Y
-32.27
14.20
3Y
-32.47
81.12
5Y
-32.60
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Simon-Thorsten Wiebusch
- Full Time Employees
- 2,807
- Sector
- Process industries
- Industry
- Chemicals: agricultural
- Address
- Bayer House Thane MA India 400607
- IPO Date
- Jan 8, 2010
- Website
- bayer.in
- Similar Companies
- Business
- Bayer CropScience Limited is an Indian agrochemical company primarily engaged in manufacturing and selling crop protection products, seeds, and digital farming solutions. Its core product portfolio includes insecticides, fungicides, herbicides, corn seeds, soybean seeds, vegetable seeds, and genetic traits designed to enhance crop performance such as drought tolerance, pest resistance, herbicide tolerance, and improved nutrition. The company also offers biological solutions like biopesticides derived from natural organisms and bio-stimulants that boost plant growth and stress resilience. Bayer CropScience serves agricultural markets across India and has an expanded footprint including operations in the Americas, Europe, and Asia, targeting commercial growers and farmers in diverse agri-climatic zones. Founded in 1967 and headquartered in Thane, India, Bayer CropScience operates as a subsidiary within the global Bayer Group. In recent developments, Bayer CropScience has strategically acquired a canola treating and packaging facility in Coaldale, Alberta, Canada from HyTech Production, enhancing its control over the entire seed production-to-packaging process to better serve farmers and optimize canola hybrid supply. The acquisition, effective November 2024, complements Bayer’s existing seed production and cleaning operations in Canada. Additionally, the company reports strong sales growth in its corn seed and traits business, with a notable 16.6% increase in quarterly sales, driven by demand for non-glyphosate-based herbicides and improved seed genetics. Bayer continues to address regulatory challenges related to glyphosate-based products like Roundup, with litigation containment efforts expected to progress by the end of 2026. These strategic moves underpin Bayer CropScience’s commitment to innovation in crop protection, seed technology, and sustainable agriculture solutions. Overall, Bayer CropScience Limited offers comprehensive crop protection chemicals; high-quality genetically improved seeds across major crops such as corn, soybean, and vegetables; integrated digital farming technologies for yield optimization; and sustainable biological farming products. Its recent operational expansion through facility acquisition and new product introductions highlights its focus on strengthening global supply chains and advancing next-generation agricultural inputs to meet evolving farmer needs. The company maintains a dominant position in the agri-care segment in India while reinforcing its international presence with strategic partnerships and investments in North America and beyond.